The global intravascular optical coherence tomography (OCT) imaging systems market is projected to be valued at over US$ 2.57 billion by the end of 2033 and grow at a compound annual growth rate (CAGR) of over 7.53% during the forecast period, 2025 to 2033.  

Optical Coherence Tomography (OCT) is a high-resolution imaging modality that produces cross-sectional images of biological tissue with micrometre resolution. It is also capable of detecting vulnerability traits and identifying the chemical composition of atherosclerotic plaques. It is the only tool present today that can measure the fibrous cap thickness, which covers the atheroma’s lipid core, making it an exceptional modality for detecting plaques prone to rupture. Intravascular OCT used coherent light which is present in the infrared region of the electromagnetic spectrum. A relatively longer wavelength is used for deeper penetration into highly scattering media. It requires an imaging element and an optical fibre for illumination and collection of backscattered light from the array wall, all this while pulling back the catheter optics and rotating at high speeds through the artery lumen. Numerous coronary imaging applications have adopted OCT and is acknowledged as safe using a sample space of a heterogeneous and unselected group of patients in different clinical settings. Higher-resolution imaging and rapid image acquisition are among the features that make OCT a superior technique compared to other modalities used in clinical practices. Additionally, the growing adoption of advanced technologies is expected to drive the adoption of intravascular OCT for clinical trials and patient evaluation, further fueling market growth during the forecast period.

Intravascular optical coherence tomography enables real-time, high-resolution imaging of coronary arteries, allowing clinicians to assess plaque morphology, stent deployment, and arterial wall characteristics. Compared to intravascular ultrasound (IVUS), IVOCT offers 10 times greater resolution, making it increasingly preferred in interventional cardiology procedures.

Market Drivers: Precision Imaging in Cardiovascular Interventions

Key growth drivers include:

  • Rise in coronary artery disease and percutaneous coronary interventions (PCIs)

  • Technological advancements in catheter-based imaging

  • Growing preference for image-guided minimally invasive surgeries

  • Favorable reimbursement policies and clinical adoption in North America and Europe

Insights on Global Intravascular Optical Coherence Tomography Market:

By Implant Type

  • Time domain intravascular OCT
  • Frequency Domain OCT

Frequency Domain OCT (FD-OCT) is a new and innovative OCT technique that achieves a data acquisition rate of 25mm/s, which can facilitate image acquisition during iodinated contrast injection, thereby eliminating the need for balloon occlusion. It is far more efficient than Time Domain OCT (TD-OCT) as it requires proximal balloon occlusion for an adequate “clearance” of light-attenuating RBCs during image acquisition. Thus, FD-OCT, due to its high efficiency, is expected to have a higher growth rate in the North American and European market spaces during the forecast period, as it becomes easier to adopt newer technologies in a patient pool with a higher spending capacity. It will take some time for emerging economies to adopt FD-OCT on a larger scale, but it is expected to provide a positive outcome during the forecast period.

By End User

  • Hospitals
  • Diagnostics Laboratories
  • Ophthalmic Clinics
  • Outpatient Centres

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

As North America and Europe are developed economies, they are expected to dominate the global market. They possess 60% share of the market and is expected to remain unchanged during the forecast period. The Asia Pacific, driven by the rise in OCT imaging adoption for clinical diagnosis, is a fast-growing market and is expected to grow at a faster rate during the forecast period. On the other hand, due to limited adoption of OCT imaging, Latin America and the Rest of the World acquire a smaller share of the global market. But these regions have potential and are good opportunities for key market players.

Major players included in the Global Intravascular Optical Coherence Tomography (OCT) Imaging Systems Market:

  • Abbott Laboratories
  • Carl Zeiss AG
  • TOPCON CORPORATION
  • Heidelberg Engineering GmbH
  • Agfa Healthcare India Pvt. Ltd.
  • Agiltron Inc.
  • Michelson Diagnostics Ltd
  • Nikon Instruments Inc.
  • Thorlabs, Inc.
  • Novartis

Recent Developments

Abbott Laboratories

A global leader in intravascular imaging, Abbott continues to dominate the OCT space with its Dragonfly™ OpStar Imaging Catheter and the Ultreon™ 1.0 Software, which integrates AI to aid in vessel visualization and lesion assessment.

  • Recent Development: In March 2024, Abbott received expanded CE Mark approval for its Ultreon software update, which adds automated stent optimization features, enabling real-time image-guided decision-making.

  • The company is also investing in combination imaging (OCT + IVUS) platforms to broaden its cardiovascular imaging portfolio.

FutureWise Key Takeaways:
•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

Objectives of the Study:

  • To provide an exhaustive analysis on the Intravascular Optical Coherence Tomography (OCT) Imaging Systems Market By Implant Type, By End-User and By Region.
  • To provide comprehensive insights on factors such as drivers, restraints, trends, opportunities, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections, which are represented in the format of data-sets and PPT.
  • To predict the market size in key regions— North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
  • To provide information on competitors, which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com